摘要
在慢性肝病的治疗中,抗纤维化的治疗是非常重要的一个方面,也是治疗中的难点。能否阻断肝纤维化的形成与发展,对阻止或延缓慢性肝病向肝硬化的转变具有重要意义。肝纤维化为诸多慢性肝病发展至肝硬化过程中所共有的病理组织学变化,是影响慢性肝病预后的重要环节,减缓或阻止肝纤维化进程是一相当重要的治疗对策,中医药主要选用活血化瘀的药物,以降解纤维组织。活血化瘀药物具有消除淤血、通行血脉、促进血行等作用,随着对活血祛瘀药的研究,将对肝纤维化的治疗开辟新的领域。
In the treatment of chronic liver disease,anti-fibrotic treatment is an important aspect and also is a difficult point.Whether formation and development of hepatic fibrosis can be blocked up or not,have important significance of preventing or delaying the change from chronic liver disease into hepatic cirrhosis.Hepatic fibrosis is the common histopathological change which many kinds of chronic liver diseases developed to hepatic cirrhosis have,and it is an important link affecting chronic liver disease prognosis.Therefore,preventing or delaying hepatic fibrosis is an important treatment method.For Chinese drugs,activating blood circulation to disspipate blood stasis drugs can be selected to degrade fibrous tissue.Activating blood circulation to disspipate blood stasis drugs can remove blood stasis,promote blood circulation,activate blood circulation,etc.With the study of activating blood circulation to disspipate blood stasis drugs,a new field will be opened up for hepatic fibrosis treatment.
出处
《齐鲁药事》
2011年第4期236-238,共3页
qilu pharmaceutical affairs
关键词
活血化瘀
中药
肝纤维化
Activating blood circulation to disspipate blood stasis
Traditional Chinese medicine
Hepatic fibrosis